Home News News archive Diamond Information |
home > news Pfizer says its vaccine trials showed a 'robust' response for kids ages 5-11 and plans to submit data to the FDA for emergency use authorization Pfizer says its vaccine trials showed a 'robust' response for kids ages 5-11 and plans to submit data to the FDA for emergency use authorizationFind this article in Google |